CVSS3
Attack Vector
PHYSICAL
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS
Percentile
27.1%
Successful exploitation of this vulnerability could cause the clinician applicationโs custom password to be reset to default, resulting in unauthorized control of the clinician therapy application.
The following versions of Medtronic Clinician App are affected:
3.2.1 UNVERIFIED PASSWORD CHANGE CWE-620
Medtronic Clinician (A51200) and InterStim X Clinicain App (A51300) contain a vulnerability that exists under certain reset conditions, which could cause the clinician applicationโs custom password to be reset to a default password. This could result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app. Changes still cannot be made outside of the established therapy parameters of the programmer. To gain unauthorized access, an individual would need physical access to the Smart Programmer.
CVE-2023-25931 has been assigned to this vulnerability. A CVSS v3 base score of 6.4 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H).
Medtronic reported this vulnerability to CISA.
The following mitigations have been provided by Medtronic:
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage at cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01BโTargeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
CISA also recommends users take the following measures to protect themselves from social engineering attacks:
No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2023-25931
cisa.gov/ics
cisa.gov/ics
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-23-061-01
cwe.mitre.org/data/definitions/620.html
global.medtronic.com/xg-en/product-security/security-bulletins/pelvic-health-interstim-micro.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=Medtronic%20Micro%20Clinician%20and%20InterStim%20Apps+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-23-061-01
us-cert.cisa.gov/ics/Recommended-Practices
us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B
www.cisa.gov/uscert/ncas/tips/ST04-014
www.cisa.gov/uscert/sites/default/files/publications/emailscams_0905.pdf
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-23-061-01&title=Medtronic%20Micro%20Clinician%20and%20InterStim%20Apps
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-23-061-01
www.oig.dhs.gov/
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=Medtronic%20Micro%20Clinician%20and%20InterStim%20Apps&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-23-061-01